Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cornea. 2008 Jun;27(5):590-4. doi: 10.1097/ICO.0b013e318169d698.

Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts.

Author information

  • 1Institute of Refractive and Ophthalmic Surgery, Zurich, Switzerland. hanspeter.iseli@iroc.ch

Abstract

PURPOSE:

To evaluate the efficacy of ultraviolet-corneal cross-linking (CXL) for treating infectious melting keratitis.

METHODS:

Five patients with infectious keratitis associated with corneal melting were treated with CXL at the outpatient departments of the Institut für Refraktive und Ophthalmo-Chirurgie and the eye hospital at the University of Zurich. CXL was performed when the infection did not respond to systemic and topical antibiotic therapy. Follow-up after cross-linking ranged from 1 to 9 months.

RESULTS:

In all cases, the progression of corneal melting was halted after CXL treatment. Emergency keratoplasty was not necessary in any of the 5 cases presented.

CONCLUSIONS:

CXL is a promising option for treating patients with therapy-refractory infectious keratitis to avoid emergency keratoplasty.

PMID:
18520510
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk